Semaglutide
Overview
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes and chronic weight management. It stimulates insulin secretion and signals to the brain to reduce appetite and caloric intake.
API suppliers (52)
Suppliers of Semaglutide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 38 of 52 suppliers.
10 of 52 hold a GMP certificate on record in the EU or UK registers
- FUJIAN GENOHOPE BIOTECH LTDChina2 active DMF GMP on record
- Yangzhou Aurisco Pharmaceutical Co.,Ltd.China2 active DMF
- SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDChina2 active DMF
- ZHEJIANG PEPTITES BIOTECH CO LTDChina2 active DMF
- VIRTU PHARMAKO (ZHEJIANG) CO LTDChina1 active DMF
- SHENZHEN JYMED TECHNOLOGY CO LTDChina1 active DMF
- AMBIO INCUnited States1 active DMF
- PolypeptideBelgium1 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- ZYDUS WORLDWIDE DMCC1 active DMF
- BACHEM INCSwitzerland1 active DMF GMP on record
- SHENZHEN READLINE BIOTECH CO LTDChina1 active DMF
- SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTDChina1 active DMF
- Beijing Ql Biopharmaceutical Co., Ltd.China1 active DMF
- HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChina1 active DMF
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- CHONGQING CHEN'AN BIOPHARMACEUTICAL CO LTD1 active DMF
- ASYMCHEM LIFE SCIENCE TIANJIN CO LTDChina1 active DMF
- CHINESE PEPTIDE COChina1 active DMF
- WUHAN MORE BIOTECHNOLOGY CO LTD1 active DMF
- HUISHENG BIOPHARMACEUTICAL CO LTD1 active DMF
- HARBIN JIXIANGLONG BIOTECH CO LTD1 active DMF
- HANGZHOU THINHEAL PHARMA-TECH CO LTDChina1 active DMF
- HANGZHOU GO TOP PEPTIDE BIOTECH CO LTDChina1 active DMF
- NINGBO KUNPENG BIOTECH CO LTDChina1 active DMF
Showing 25 of 52 suppliers — see the full list in the app.
Patent & exclusivity (US)
Per the FDA Orange Book (28 approved US products), the latest listed US patent on Semaglutide expires 17 Feb 2041 and exclusivity 19 Mar 2029. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Semaglutide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.